Infective endocarditis caused by Staphylococcus lugdunensis is a rare disease. Since its first description in 1988, there have only been a few reports of this disease and the causative organism. These publications were primarily case reports and brief case series. We conducted a literature review to identify the nature of the disease and its risk factors.
Introduction
Staphylococcus lugdunensis is a species of coagulase-negative staphylococci (CoNS), which was first described by Freney et al in 1988. S. lugdunensis is differentiated from other CoNS by its ability to produce ornithine decarboxylase and pyrrolidonyl arylamidase (PYR). It is commonly found on the human skin and is a rare contaminant in culture. Since its first identification, many publications have recognized its [1] [2] [3] [4] The first case of IE caused by S. lugdunensis was described in 1988. 5 Since then, only a few case reports and brief case series have been published regarding IE caused by S. lugdunensis. Most of these reports revealed that IE caused by S. lugdunensis could be very aggressive and that mortality was high. These characteristics of S. lugdunensis IE differed largely from other CoNS IE.
Original Article

Staphylococcus lugdunensis
A 16-year-old girl without remarkable past history was admitted to our hospital because of right flank pain and fever. S. lugdunensis was isolated in two separate sets of blood cultures. Echocardiography showed vegetation at the mitral valve, therefore surgery was performed and the outcome was fair without complications.
To provide more insight into the clinical presentations and to evaluate prognostic factors associated with the mortality of this disease, we have extensively reviewed the literature including our one recent case that was treated successfully.
Methods
We conducted a systematic Medline review covering the period January 1, 1988 through to June 30, 2008 . The search terms used were "endocarditis" and "Staphylococcus lugdunensis". The searches focused on peer-reviewed articles published in English. After locating the bibliographic references, we retrieved the abstracts of all selected articles. Two clinicians read the abstracts and complete articles independently and, by consensus, decided upon the articles to be included in the study.
The retrieved articles were included in this study if the case reported met the modified Duke criteria of IE with isolates of S. lugdunensis. 6 These articles must contain specific information regarding clinical, microbiological, therapy and outcome variables. For each patient reported, the following variables were recorded: demographic data (age and sex), clinical data (year of diagnosis, portal of entry, sites and types of involved valves and initial echocardiography findings), microbiological data (susceptibility of S. lugdunensis), therapy (antimicrobial treatment with or without surgery), and outcome (death or recovery). 
Statistical analysis
Results
A total of 67 cases of S. lugdunensis IE were included. In our comprehensive review of the literature from 1988 to 2008, 66 cases were identified from 27 articles. [5] [6] [7] 28 One case was recently treated successfully from our hospital. All of the 67 cases met the modified Duke criteria. None of the patients were injection drug users. Table 1 shows the overall characteristics of the cases reported. The mean age of cases was 53.9 years (range, 7-82 years). Forty-one (61.2%) cases involved males and 41 cases (61%) were older than 50 years. Forty-five (67.2%) cases were community-acquired with an unknown portal of entry. Thirty-six cases (65.5%) had co-morbidities. Native valve, prosthetic valve and pacemaker IE accounted for 80.6%, 11.9% and 7.5% of cases, respectively. Antimicrobial susceptibility reports were available in 50 patients, of which 82.0% (41 patients) were susceptible to penicillin. About 87% of IE cases occurred on the left side. Of the left-side lesions, mitral valve, aortic valve and both represented 40.3%, 32.8% and 11.9% of the total cases. Eight (11.9%) cases had multi-valvular involvement, and all multi-valvular lesions were on the left side. Eleven (16.4%) cases had the occurrence of embolization. Among 54 patients that received echocardiography examinations, vegetation could be detected in 42 (77.8%) cases. Forty-six (68.7%) cases received both antimicrobial therapy and surgery. The overall mortality rate of S. lugdunensis IE was 38.8%. Table 2 shows the comparison between the dead and surviving cases with S. lugdunensis IE. The mortality rates for native valve endocarditis, prosthetic valve endocarditis and pacemaker lead endocarditis were 34.6%, 75% and 20%, respectively. Upon univariate analysis, variables that had significant association with mortality included: age greater than 50 years, medical treatment alone, negative echocardiography findings and diagnosis before 1995. In the multivariate logistic regression analysis, medical treatment alone was an independent risk factor for mortality (odds ratio = 4.79; 95% confidence interval = 1.16-19.78) ( Table 3 ).
Discussion
S. lugdunensis was first described in 1988 by Freney et al. S. lugdunensis is differentiated from other CoNS by the ability to produce ornithine decarboxylase and PYR. S. lugdunensis shares some properties with S. aureus. Both may express clumping factor and/or a thermostable DNase and have the same virulence determinants. 29 The colony morphology of S. lugdunensis also resembles S. aureus and may be accidentally identified as S. aureus. 30 Approximately 25%
of clinical isolates of S. lugdunensis produce extracellular slime or glycocalyx, which plays an important role in bacterial colonization and interferes with the phagocytosisassociated activities of neutrophils. According to the published reports, the clinical presentations of IE caused by CoNS were different from those caused by S. aureus in many ways. [31] [32] [33] Although S. lugdunensis is a CoNS, some reports have showed that the presentation of S. lugdunensis IE was more similar to S. aureus IE than to IE caused by other CoNS. [34] [35] [36] In our study, S. lugdunensis IE usually developed in the cases aged above 50 years. Most patients acquired the infection in the community and the sites of entry were not identified. Most strains of S. lugdunensis isolated were sensitive to penicillin. S. lugdunensis usually invades the left-side valves with mitral or aortic valve involvement. Sometimes, both mitral and aortic valves could be involved simultaneously. The majority of cases were in the native valve, and IE caused by other CoNS were often hospital-acquired and related to indwelling devices. 31, 33 CoNS usually invaded prosthetics valves 37 and most CoNS were resistant to penicillin. 38 These were the characteristics of S. lugdunensis that differed from other CoNS. In our review, 68.7% (46/67) of patients received valve replacement and the rate of surgery was higher than for In one series, S. lugdunensis IE often caused valve destruction with abscess formation and progressed to congestive heart failure rapidly. 2 The antimicrobial treatment usually could not completely eradicate the infectious processes in most cases. Finally, surgical interventions with valve replacement were often needed in most cases reported. Our study showed that surgery was the only independent risk factor for mortality. In our review, the mortality rate associated with S. lugdunensis IE was 38.8%. In a previous series, the overall mortality of IE ranged from 18.0% to 24.6%. [39] [40] [41] [42] In a study of 558 patients with S. aureus endocarditis from 2003, the mortality rate was 22.4%. 43 According to Whitener et al in 1993, the mortality rate of CoNS IE was 16%. 33 Compared with these results, the mortality of S. lugdunensis endocarditis appeared to be higher. Further analysis should be performed to verify this hypothesis. Prosthetic valve endocarditis accounted for 11.9% of S. lugdunensis endocarditis cases. These patients often had greater comorbidity because of underlying cardiac problems. Deterioration of clinical conditions often delayed operations for valve replacement, and sometimes only conservative treatment was suggested. Overall, pacemaker lead endocarditis constituted 8.2% of S. lugdunensis endocarditis cases and the mortality rate was 20%. Removal of the bacteria with antimicrobial therapy was commonly used in these patients and mortality was low compared with other subgroups.
Most isolates of S. lugdunensis (82%) were susceptible to penicillin. In studies by Auguera et al and Zinkernagel et al, most isolates of S. lugdunensis were susceptible to penicillin. 2 Unlike most CoNS, isolates of S. lugdunensis were also generally susceptible to multiple agents. In 2006, Hellbacher analyzed 39 isolates of S. lugdunensis and demonstrated that S. lugdunensis isolates were generally susceptible to most of the antibiotics currently used. 30 Despite the remarkable susceptibility to a wide array of antimicrobial agents, medical treatment alone was seldom successful and the majority of patients still received surgery for valve replacement. Most microbiological laboratories do not routinely identify CoNS to the species level. Additionally, both S. lugdunensis and S. aureus could be positive in the latex agglutination test because they show similar colony morphology and produce clumping factor. Thus, S. lugdunensis might be misidentified as S. aureus in routine microbiological laboratory tests. Because of the enhanced virulence and destructive nature of S. lugdunensis, the prompt identification of this organism to the species level is essential whenever it is suspected. If a very aggressive form of S. aureus IE is encountered, the possibility of S. lugdunensis IE should also be considered. There are several biochemical tests able to identify S. lugdunensis easily. First, S. lugdunensis reveals a negative result in tube coagulase tests. Furthermore, S. lugdunensis can be positively differentiated from other CoNS due to positive PYR reaction and positive ornithine decarboxylase activity.
There are some limitations in this study. The main source of information was cases reported in the literature. There is potential for significant selection bias for higher severity, a more complicated course and poorer outcome so that these cases were more likely to be published. In addition, individual investigator's reports could not be standardized for patients' variables and a bias might exist. Some of the sickest patients who might be considered surgical candidates were excluded from surgical options, and certain subgroups of a small number of cases may produce type II errors.
Although uncommon, S. lugdunensis is a very aggressive and destructive pathogen with a major role in IE. Examination of the limited data available would suggest surgery appears to be the preferred choice of treatment. In the future, with more cases published from series reports, there should be sufficient cases for more detailed analysis, and hopefully the inherent bias of the analysis will be decreased. 
